

10 Jun 2026
// GLOBENEWSWIRE
https://www.globenewswire.com/news-release/2026/06/10/3309607/0/en/artelo-biosciences-presents-art26-12-human-metabolite-data-demonstrating-favorable-drug-metabolism-characteristics-associated-with-clinical-development-success.html

20 Apr 2026
// GLOBENEWSWIRE
https://www.globenewswire.com/news-release/2026/04/20/3276908/0/en/artelo-announces-peer-reviewed-publication-supporting-its-fabp5-inhibitor-art26-12-as-a-novel-pain-treatment-with-a-potentially-first-in-class-profile.html

15 Oct 2025
// GLOBENEWSWIRE
https://www.globenewswire.com/news-release/2025/10/15/3167179/0/en/Artelo-Biosciences-Announces-Expanded-Clinical-Data-to-be-Presented-on-both-ART26-12-and-ART27-13-at-the-8th-Annual-Cannabinoid-Endocannabinoid-Drug-Development-Summit.html